" class="no-js "lang="en-US"> Sajid Javid Archives - Page 4 of 5 - Medtech Alert
Saturday, September 13, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Young People Aged 12 to 15 to be Offered a COVID-19 Vaccine

People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech […]

G20 Ministerial Health Declaration Published

G20 health ministers have united to pledge global action to improve future health security, increase […]

Additional £5.4 Billion for NHS Covid Response Over Next Six Months

The NHS will receive an extra £5.4 billion over the next six months to support […]

New Study to Test Third COVID-19 Vaccine for People with Weakened Immune Systems

A new clinical trial to determine whether a third dose of vaccine will improve the […]

Government Launches First UK-wide Antibody Surveillance Programme

Thousands of adults a day will be given free access to antibody tests through a […]

Health Secretary Opens New Cancer Hospital

Thousands of patients in Cumbria are set to benefit from state-of-the-art cancer diagnosis and treatment […]

First Monoclonal Antibody Treatment for COVID-19 Approved for Use in the UK

Following on from a thorough review of the evidence carried out by the MHRA, and […]

NHS COVID-19 App Updated to Notify Fewer Contacts to Isolate

The public is being urged to continue to use the NHS COVID-19 app as changes […]

Amanda Pritchard Appointed NHS Chief Executive

Amanda Pritchard has today been appointed as the new Chief Executive Officer of NHS England. […]

Theme Park Joins NHS Covid Vaccine Drive

Thorpe Park Resort will today (Thursday) join the roll-call of iconic locations to take part […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more